Abstract:Depression has been associated with poor performance following errors, but the clinical implications, response to treatment and neurobiological mechanisms of this post-error behavioral adjustment abnormality remain unclear. To fill this gap in knowledge, we tested depressed patients in a partial hospital setting before and after treatment (cognitive behavior therapy combined with medication) using a flanker task. To evaluate the translational relevance of this metric in rodents, we performed a secondary analys… Show more
“…Building on these clinical findings, we reported that rats given corticotropin-releasing factor, a peptide that causes myriad signs of stress and depression in humans and laboratory animals, in an attention task showed similar reductions in posterror accuracy. This effect was attenuated by JDTic, a kappa-opioid receptor antagonist with antidepressant-like effects (Beard et al, 2015). These findings indicate that depression-like impairments in cognitive control can be recapitulated in rodents and are sensitive to classes of drugs under investigation for treating depression, opening exciting translational avenues.…”
“…Building on these clinical findings, we reported that rats given corticotropin-releasing factor, a peptide that causes myriad signs of stress and depression in humans and laboratory animals, in an attention task showed similar reductions in posterror accuracy. This effect was attenuated by JDTic, a kappa-opioid receptor antagonist with antidepressant-like effects (Beard et al, 2015). These findings indicate that depression-like impairments in cognitive control can be recapitulated in rodents and are sensitive to classes of drugs under investigation for treating depression, opening exciting translational avenues.…”
“…Specifically, prior research using Eriksen Flanker and Stroop paradigms in acute MDD have shown evidence of poorer post-error adjustments (Beard et al, 2015), abnormal ERN (Chiu and Deldin, 2007) and Pe amplitudes (Schrijvers et al, 2008; Olvet et al, 2010), as well as disrupted frontocingulate activation (Holmes and Pizzagalli, 2008), and neuroimaging studies have consistently observed depression-related deficits in regions of the dlPFC, dmPFC and ACC (Fitzgerald et al, 2008) that may contribute to these impairments. These regions are known to be highly sensitive to stress-related excesses in catecholamine and glucocorticoid levels (Arnsten, 2009), and this may explain the exacerbation of prefrontal dysfunction in stress-sensitive populations, such as those with rMDD.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, ruminative thinking and poor regulation of sad mood are associated with difficulty disengaging from negative information and modifying behavior accordingly. For example, on tests of performance monitoring that require rapid, accurate responding (e.g., the Eriksen Flanker task), individuals with MDD perform poorly on trials following a commission error (Holmes and Pizzagalli, 2008; Beard et al, 2015), indicating the presence of an oversensitive error-detection system, or a failure to recruit control systems to adaptively respond to errors.…”
Deficits in cognitive control are a hallmark characteristic of depression, however less is known about the degree to which they persist beyond symptom remission and might contribute to symptom recurrence in remitted individuals (rMDD). Evidence indicates that stress interferes with cognitive control, highlighting a potential mechanism by which stress precipitates depression relapse. Therefore, this study examined whether stress exposure elicits deficits in error monitoring – a component of cognitive control thought to be particularly implicated in the ability to adaptively respond to negative feedback – in individuals with rMDD. Unmedicated individuals with rMDD (n=30) and healthy controls (n=34) performed an Eriksen Flanker task before and 45 minutes after an acute stressor while 128-channel event-related potentials (ERPs) were recorded. Flanker interference effects and post-error adjustments were examined, and ERP analyses focused on the error-related negativity (ERN) and error positivity (Pe). Standardized low resolution electromagnetic tomography (sLORETA) was used to examine stress-induced changes in current source density. Individuals with rMDD showed blunted cortisol reactivity to the stressor, coupled with heightened self-reported stress reactivity. Although no significant effects of group or stress were observed in scalp-level ERPs, source-level analyses indicated that among the rMDD group only, stress caused a reduction in activation in frontocingulate regions critically implicated in error monitoring. The magnitude of stress-induced decreases in frontocingulate activation correlated with heightened self-reported stress reactivity, and also predicted heightened levels of stress and depression 18 months later in the entire sample. These findings suggest that individuals with rMDD show a stress-induced disruption in frontocingulate function that is linked to heightened stress reactivity, and this disruption prospectively predicts heightened levels of future stress and depressive symptomatology.
“…In this latter instance, these manipulations did not affect choice behavior, suggesting that the mechanisms through which increased CRF transmission alters choice latencies may be dissociable from those involved in biasing the direction of choice. Notably central CRF infusions have been reported to increase choice latencies during tests of attention ( Van't Veer et al, 2012;Beard et al, 2015). These findings suggest that the ability of acute stress to induce 'indecisiveness' and increase processing times for action selection is also mediated in part by increased central CRF transmission.…”
Section: Cognitive/motivational Alterations Induced By Increased Crf mentioning
Acute stress activates numerous systems in a coordinated effort to promote homeostasis, and can exert differential effects on mnemonic and cognitive functions depending on a myriad of factors. Stress can alter different forms of cost/benefit decision-making, yet the mechanisms that drive these effects remain unclear. In the present study, we probed how corticotropin-releasing factor (CRF) may contribute to stress-induced alterations in cost/benefit decision-making, using an task where well-trained rats chose between a low effort/ low reward lever (LR; two pellets) and a high effort/high reward lever (HR; four pellets), with the effort requirement increasing over a session (2, 5, 10, and 20 presses). One-hour restraint stress markedly reduced preference for the HR option, but this effect was attenuated by infusions of the CRF antagonist, alpha-helical CRF. Conversely, central CRF infusion mimicked the effect of stress on decision-making, as well as increased decision latencies and reduced response vigor. CRF infusions did not alter preference for larger vs smaller rewards, but did reduce responding for food delivered on a progressive ratio, suggesting that these treatments may amplify perceived effort costs that may be required to obtain rewards. CRF infusions into the ventral tegmental area recapitulated the effect of central CRF treatment and restraint on choice behavior, suggesting that these effects may be mediated by perturbations in dopamine transmission. These findings highlight the involvement of CRF in regulating effort-related decisions and suggest that increased CRF activity may contribute to motivational impairments and abnormal decision-making associated with stress-related psychiatric disorders such as depression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.